San Francisco, CA USA
October 10-11, 2018


2018 Speaking Faculty

The full Speaking Faculty for this event has not yet been announced. Please check back in the coming days or join our mailing list for regular updates.


Conference Chair

William Schmidt, Ph.D.

Northstar Consulting


Speaking Faculty

  • Michael Palfreyman, Ph.D., DSc.

  • Chief Scientific Officer
  • Amorsa Therapeutics

  • Nathaniel Katz, MD, MS

  • Chief Executive Officer
  • Analgesic Solutions

  • Philippe Diaz, Ph.D.

  • Associate Professor: Co-Founder and Chief Scientific Officer
  • University of Montana; DermaXon

  • Neil Singla, MD

  • Chief Scientific Officer
  • Lotus Clinical Research

  • David Yeomans, Ph.D.

  • Director of Pain Research, Professor of Anesthesia
  • Stanford University School of Medicine

  • Robert H. Dworkin, Ph.D.

  • Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry, Director, Anesthesiology Research Center
  • University of Rochester School of Medicine and Dentistry

  • Simon Westbrook, Ph.D.

  • CEO and Founder
  • Levicept

  • Mike Royal, MD

  • Chief Medical Officer
  • Concentric Analgesics

  • Tony Yaksh, Ph.D.

  • Professor, Departments of Anesthesiology and Pharmacology
  • University of California, San Diego

  • Robert Cowan, MD, FAAN

  • Clinical Professor, Neurology and Neurological Sciences
  • Stanford University School of Medicine

  • Alex Bekker, MD, Ph.D.

  • Chair, Department of Anesthesiology, Professor, Department of Physiology and Pharmacology
  • Rutgers New Jersey Medical School

  • Tad Seifert, MD

  • Director, Sport Neurology Program; Head
  • Norton Healthcare; NCAA Headache Task Force

  • Srdjan Nedeljkovic, MD

  • Associate Professor, Anesthesia and Pain Management
  • Harvard Medical School, Brigham and Women's Hospital

  • Shafaq Sikandar, Ph.D.

  • Research Fellow
  • University College London

  • Joseph Foss, MD

  • Founder
  • Neurotherapia

  • Sean Mackey, MD, Ph.D.

  • Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab
  • Stanford University School of Medicine

Download Brochure

Speaking Opportunities

Sponsor/Exhibit Opportunities

Join Conference Mailing List

About Us

Arrowhead Publishers' conferences offer more than simply presentations; we offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward. 

Contact Us

For general information about the conference, please contact us at:
 This email address is being protected from spambots. You need JavaScript enabled to view it.
  PO Box 96, Chanhassen, MN 55317 USA


Join Our Mailing List
Please fill out the following form in order to receive occasional updates regarding this conference, including updates regarding the agenda, speaker additions and conference promotions and DISCOUNTS.
We never share your personal data with anyone else, EVER!
Michael G. Palfreyman, Ph.D., DSc.

Chief Scientific Officer, Amorsa Therapeutics

Michael Palfreyman is a seasoned leader in the biotechnology and pharmaceutical industries with over 40 years experience in drug discovery, pre-clinical and early clinical development. He has directed research programs in Psychiatric, Neurological, Cardiovascular, Cancer, Infectious, Metabolic and Respiratory Disorders, Dr. Palfreyman’s own research includes discovery and development of a number of psychotherapeutic compounds including antipsychotics, antidepressants, anti-epileptics, analgesics, anti-Parkinson’s, anti-emetics, cognition enhancers and Alzheimer’s treatments. Many of these compounds have entered clinical development and a number have reached the market place. 

He is a Fellow of the American College of NeuroPsychopharmacology and he is a qualified Pharmacist and Founding Member Royal Pharmaceutical Society of Great Britain. He is the co-inventor of 53 issued US and European patents, 4 pending patents and co-author of over 100 peer reviewed scientific articles, has edited books on glutamate antagonists and enzyme inhibitors and authored several book chapters on a number of different therapeutics. He is currently Chief Scientific Officer at Amorsa Therapeutics.